XERIS BIOPHARMA HOLDINGS, INC. (XERS) /
The debt of XERIS BIOPHARMA HOLDINGS, INC. over the past 6 years
Chart XERIS BIOPHARMA HOLDINGS, INC.: liquid cash, total debt, net cash, fiscal 2020–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, XERIS BIOPHARMA HOLDINGS, INC. had liquid cash of $111.04M and total debt of $220.34M: net debt of $109.29M. It had more liquid cash than debt at 2 of the 6 year-ends shown. Total debt was highest at the end of fiscal 2024 ($232.11M) and lowest at the end of fiscal 2020 ($87.02M).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $111.04M | $220.34M | -$109.29M |
| 2024ended Dec 31, 2024 | $71.62M* | $232.11M | -$160.49M |
| 2023ended Dec 31, 2023 | $72.45M* | $190.93M | -$118.48M |
| 2022ended Dec 31, 2022 | $121.97M* | $187.07M | -$65.11M |
| 2021ended Dec 31, 2021 | $102.43M* | $88.07M | $14.37M |
| 2020ended Dec 31, 2020 | $133.79M* | $87.02M | $46.77M |
Fiscal years as XERIS BIOPHARMA HOLDINGS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on XERIS BIOPHARMA HOLDINGS, INC.
- The revenue of XERIS BIOPHARMA HOLDINGS, INC.
- The profitability of XERIS BIOPHARMA HOLDINGS, INC.
- The cash flow of XERIS BIOPHARMA HOLDINGS, INC.
- All of XERIS BIOPHARMA HOLDINGS, INC.'s financials, charted
Companies of a similar size
- VCELVERICEL CORPORATION
- BANCBANC OF CALIFORNIA, INC.
- DRHDIAMONDROCK HOSPITALITY CO
- CIFRCipher Digital Inc.
- ATRCAtriCure, Inc.
Not investment advice. This page shows what XERIS BIOPHARMA HOLDINGS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.